0001894562-24-000037.txt : 20240614 0001894562-24-000037.hdr.sgml : 20240614 20240614165856 ACCESSION NUMBER: 0001894562-24-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240612 FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Foster-Cheek Kaye I CENTRAL INDEX KEY: 0001312622 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41536 FILM NUMBER: 241045707 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prime Medicine, Inc. CENTRAL INDEX KEY: 0001894562 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 FIRST ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-465-0013 MAIL ADDRESS: STREET 1: 60 FIRST ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 wk-form4_1718398728.xml FORM 4 X0508 4 2024-06-12 0 0001894562 Prime Medicine, Inc. PRME 0001312622 Foster-Cheek Kaye I C/O PRIME MEDICINE, INC. 60 FIRST STREET CAMBRIDGE MA 02141 1 0 0 0 0 Stock Option (right to buy) 7.68 2024-06-12 4 A 0 45000 0 A 2034-06-12 Common Stock 45000 45000 D The shares subject to this option shall vest in full upon the earlier of (i) June 12, 2025 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date /s/ Karen Brown, attorney-in-fact 2024-06-12